Gastrointestinal Research

Innovative clinical trials focusing on inflammatory bowel diseases, including studies of novel therapies for both Crohn’s Disease and Ulcerative Colitis. Research evaluates treatments like obefazimod and risankizumab for managing moderate to severe cases.

  • Crohn’s Disease Management
  • Ulcerative Colitis Treatment
  • Inflammatory Response Studies

Cardiovascular Studies

Comprehensive research into cardiovascular diseases, examining new treatments for heart attacks, stroke prevention, and atherosclerosis. Studies include evaluation of medications like asundexian and inclisiran for various cardiac conditions.

  • Stroke Prevention
  • Heart Attack Treatment
  • Atherosclerosis Management

Neurological Research

Advanced trials in multiple sclerosis treatment, testing innovative therapies like frexalimab and remibrutinib. Research focuses on reducing relapse rates and improving long-term patient outcomes.

  • Multiple Sclerosis Therapy
  • Disease Modification
  • Neurological Response Studies

Kidney and Metabolic Disorders

Studies examining treatments for chronic kidney disease and related conditions, including research on combination therapies with dapagliflozin and investigations into hypertriglyceridemia management.

  • Renal Function Studies
  • Hypertension Management
  • Metabolic Disease Research